14/03/2026
Morvan syndrome
is a rare autoimmune neurological disorder characterized by peripheral nerve hyperexcitability and central nervous system involvement. It typically presents with a combination of continuous muscle twitching (neuromyotonia), severe insomnia, autonomic dysfunction, and neuropsychiatric symptoms such as confusion, hallucinations, agitation, or memory disturbance. Patients may also develop excessive sweating, tachycardia, weight loss, and neuropathic pain. The syndrome is most commonly associated with antibodies against voltage-gated potassium channel (VGKC) complex proteins, particularly CASPR2 (Contactin‑Associated Protein‑like 2) and sometimes LGI1 (Leucine‑Rich Glioma‑Inactivated 1). In some cases it can be related to tumors such as Thymoma. Diagnosis is based on clinical features, antibody testing, and electrophysiological studies that may show neuromyotonic discharges. Treatment generally includes immunotherapy such as corticosteroids, intravenous immunoglobulin, plasma exchange, or other immunosuppressive therapies, along with symptomatic management. Early recognition and treatment can significantly improve the prognosis.